The sensitivity to identify microscopically confirmed prostate abnormalities was 40% (95% CI: 24.9-56.7) with TRUS guided prostate biopsy of MRI identified lesions and 80% (95% CI: 64.4-90.9) with ...

In a study, they found that prostate MRI missed 13% of high-grade prostate tumors that were revealed by subsequent standard template transrectal ultrasound (TRUS) 12-core biopsy.

Rates of severe infection after transrectal ultrasound-guided (TRUS) prostate biopsy that require hospitalization are on the rise, a population-based Swedish study shows. "Over 100,000 biopsies ...

Of the GGG 1 patients, 9,248 were diagnosed by a transrectal ultrasound (TRUS) biopsy while 980 were diagnosed by a combination of TRUS and MRI.

Transperineal magnetic resonance imaging-transrectal ultrasound (MRI-TRUS) fusion prostate biopsy under local anesthesia without antibiotic prophylaxis can be performed safely and is well ...

The current standard, a systematic 12-core transrectal ultrasound-guided (TRUS) biopsy (TRUS-Bx), can potentially lead to overdiagnosis in low-risk prostate cancer and underdiagnosis in some cases ...

Purpose: The current tumor-node metastasis (TNM) staging system classifies impalpable prostate cancers identified by needle biopsy and invisible by imaging as T1c and those visible as T2. Palpable ...

Ultrasound scan of a prostate on an isolated white background. The picture of the prostate is in the doctor's hand. One in eight men will develop prostate cancer in their lifetime.

Oncology/Hematology > Prostate Cancer Year in Review: Prostate Cancer — PSMA-targeted imaging agent approvals, MRI-targeted biopsies, and genomic testing by Mike Bassett, Staff Writer, MedPage ...

RICHMOND, Va. — A groundbreaking treatment for prostate cancer now available in Virginia aims to improve patient outcomes while minimizing side effects associated with traditional surgeries and ...